Aldevron Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Aldevron's estimated annual revenue is currently $85.4M per year.
- Aldevron received $Undisclosed in venture funding in January 2017.
- Aldevron's estimated revenue per employee is $155,000
- Aldevron has 551 Employees.
- Aldevron grew their employee count by 29% last year.
- Aldevron currently has 1 job openings.
What Is Aldevron?
Aldevron provides contract manufacturing and scientific services. We specialize in plasmid DNA, protein production, and antibody generation. PLASMID DNA PRODUCTION With the successful completion of over 50,000 projects, we have developed unsurpassed expertise in plasmid manufacturing. Using proprietary technology, Aldevron manufactures DNA for a wide range of research, preclinical, clinical, and diagnostic applications (1 mg to 100 g). PROTEIN PRODUCTION Aldevron offers a wide range of protein services including host cell optimization, expression screening, process development, contract production, enzyme and antibody assay design, and more. Proteins produced by Aldevron are used for a wide range of agriculture and biomedical applications from research grade to full cGMP. ANTIBODY GENERATION GENOVAC Antibody Technology supports all project types from reagent antibodies to diagnostic and therapeutic applications with high success rates. Based on many years of experience, our immunization technology has been developed to cater for all protein targets where other methods have failed (including e.g. GPCRs). Our custom antibodies have been validated in over 130 publications and patents for more than 500 clients worldwide. Additional services include antibody processing, production, labeling, characterization and sequencing.keywords:Biotechnology,Healthcare,Pharmaceuticals